Author

María Manuela Clavijo

Observed names: Clavijo Manuela, Clavijo, M.M., Clavijo, María Manuela, M. Clavijo, MM. Clavijo, María M Clavijo

Institution: Hospital Alemán

Observed institution: Hospital Alemán

ORCID: 0000-0002-6160-9915

Observed ORCID: 0000-0002-6160-9915

OpenAlex ID: A5085331063

Risk factors and role of low molecular weight heparin in obstetric complications among women with inherited thrombophilia – a cohort study

2019 · María Manuela Clavijo, Carolina Valeria Mahuad, et al. · Hematology Transfusion and Cell Therapy · 17

Mild COVID-19 Illness as a Risk Factor for Venous Thromboembolism

2021 · María Manuela Clavijo, María de los Angeles Vicente Reparaz, et al. · Cureus · 10

Retrospective Multicenter Real-Life Study on the First-Line Treatment of Classical Hodgkin Lymphoma in Argentina

2022 · Carolina Mahuad, Otero Victoria, et al. · Clinical Hematology International · 5

Clinical characteristics, prognosis, and achievement of transplant in adolescents and adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in Argentina

2026 · María Manuela Clavijo, Juan Ignacio Ruiz, et al. · Hematology Transfusion and Cell Therapy

Extended thromboprophylaxis after hip fracture surgery: Real-world evidence of direct oral anticoagulants versus low molecular weight heparin of unfractionated heparin

2026 · María Manuela Clavijo, Juan Ignacio Ruiz, et al. · PLoS ONE

Extended Thromboprophylaxis After Hip Fracture Surgery: Real-World Evidence of Direct Oral Anticoagulants Versus Low Molecular Weight Heparin or Unfractionated Heparin

2026 · Clavijo, María Manuela · Zenodo (CERN European Organization for Nuclear Research)

[Antithrombotic therapy in deep venous thrombosis associated with port-a-cath catheter in patients with cancer: evidence in Argentina].

2025 · Andrea C Muñoz Cárdenas, María M Clavijo, et al. · PubMed

Use of direct oral anticoagulants and low molecular weight heparin in venous thromboembolism associated with cancer: real-world evidence in Argentina

2023 · MM. Clavijo, JI. Ruiz, et al. · Expert Review of Hematology

P536: Value of Measurable Residual Disease by Multiparametric Flow Cytometry in Non-promyelocytic Acute Myeloid Leukemia. Real World Evidence

2022 · A. D. Gimenez Conca, J. Gonzalez, et al. · HemaSphere

Pb1829: Argentinean Real World Experience on Midostaurin Plus Intensive Chemotherapy Vs Intensive Chemotherapy to Treat Flt3 Positive Acute Myeloid Leukemia Patients

2022 · A. Navickas, J. González, et al. · HemaSphere

Tromboprofilaxis para pacientes obesos quirúrgicos

2019 · Agostina Delorenzi, María Manuela Clavijo, et al. · Revista Hematología

Works count: 12

Citation count: 32

H-index: 3

I10-index: 2